Idoven’s Post

Mayo Clinic Researchers Harness AI for Advanced Cardiovascular Predictions Mayo Clinic researchers utilize AI to extract functional and physiological #data from routine coronary #angiography. Advanced #machinelearning techniques are employed to analyze 20,000 angiograms, predicting key cardiovascular #biomarkers with an accuracy of 80% or higher. Algorithms are trained to extract data on #ventricular functions, intracardiac filling pressures, and cardiac index, validated against echocardiography and right heart catheterization measures. Plans include refining algorithms to predict additional measures like heart valve calcium and pericardial restriction, aiming to integrate them into real-time catheterization lab dashboards. AI serves as a valuable tool, supplementing clinicians' abilities and allowing them to focus on higher-yield tasks. Despite #AI's potential, widespread adoption may face challenges due to infrastructure limitations and healthcare system dynamics, requiring clear cost-saving benefits for investment. For more information: https://lnkd.in/eGAG6uy9 #AIinCardiology #MayoClinicResearch #CardiovascularAI #MachineLearning #HealthTech #Innovation #PredictiveAnalytics #MedTech #HeartHealth #ClinicalResearch

Nice overview from MassDevice on the latest 𝐀𝐈-𝐃𝐫𝐢𝐯𝐞𝐧 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐂𝐚𝐫𝐞 #AI -powered technologies are revolutionizing #cardiology by improving #diagnostics, #patientoutcomes, and clinical #workflows. 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐓𝐨𝐨𝐥𝐬: AI algorithms analyze ECGs and ultrasounds, providing more accurate and faster diagnoses (AliveCor, Philips UltraSight, HeartBeam Inc. (NASDAQ: BEAT)). 𝐑𝐞𝐦𝐨𝐭𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠: AI-enabled devices facilitate #remotemonitoring, enhancing patient care through real-time data analysis (Medtronic, Exo, BIOTRONIK). 𝐏𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐯𝐞 𝐂𝐚𝐩𝐚𝐛𝐢𝐥𝐢𝐭𝐢𝐞𝐬: AI predicts conditions like #AFib, leading to early interventions and better patient outcomes (Volta Medical, Biosense Webster). AI in cardiology will continue to evolve, potentially leading to fully #autonomous diagnostic systems, #personalizedtreatment plans, and enhanced #predictive models for various heart conditions. https://lnkd.in/eVVnzC4K

Advancing Cardiac Care: AI in Aortic Stenosis Management Discover the power of AI in transforming cardiac care! 🚀 Our latest article explores how AI predicts aortic stenosis progression, offering hope for early intervention. #AIinHealthcare #CardiacCare #AorticStenosis #DigitalHealth 👉 Read our article to see how AI-driven diagnostics like the DASSi index are reshaping patient outcomes. Let's embrace the future of personalised heart health together! #Innovation #HealthTech #PersonalisedCare https://lnkd.in/dGuNk8Vk

We're entering a new era in #cardiaccare where #personalizedmedicine is becoming a reality. #AI and #multimodalimaging are revolutionizing how we approach #heartdisease, offering less invasive procedures and tailored treatments. Recent advancements show how AI can predict patient outcomes with remarkable accuracy, enabling better treatment decisions and improving patient care. By integrating data from electrocardiography, echocardiography, and MRI, clinicians can make informed decisions that significantly enhance patient outcomes. More on my op-ed published by Asian Hospital and Healthcare Managemente here: https://lnkd.in/gVhdC7WW

Exciting news in the world of cardiac care! Volta Medical and GE HealthCare have joined forces to revolutionize AI-powered atrial fibrillation (AFib) treatment. This ground-breaking collaboration integrates Volta's AF-Xplorer AI solution with GE HealthCare's Prucka 3 platform and CardioLab EP Recording System, promising enhanced performance and streamlined workflows for electrophysiologists. Théophile Mohr Durdez, CEO of Volta Medical, emphasizes the importance of this partnership: "Our mission to combat complex heart rhythm diseases relies on optimizing interoperability. Through this collaboration with GE HealthCare, we are advancing the frontier of current clinical applications in the field of electrophysiology." Devon Bream, GE HealthCare's Global GM for Invasive Cardiology, adds: "Volta Medical's AI-driven solutions hold promise in consolidating and simplifying data, as well as assisting clinicians in making treatment decisions for their patients." This collaboration marks a significant step forward in AFib management, combining advanced EP recording capabilities with AI-driven insights to improve patient care. https://lnkd.in/embAyi4Y 📰 Stay ahead of the curve by following Practical Patient Care on LinkedIn for more industry news and insights. #PracticalPatientCare #HealthTech #AI #Cardiology #MedicalInnovation

We are thrilled to be featured in Radiology Today for our article on Computed Tomography.🙌 Did you know, by 2050, over 35 million new cancer cases are expected—a 77% rise from 2022.🩺 Early detection of cancer or any other disease can significantly increase the chances of successful treatment.💊 Computed Tomography (CT) procedures have emerged as a revolutionary tool in modern health care. They offer unparalleled insights into the human body that can detect diseases at their most treatable stages.🩻 The CT industry is relying on the digitalization of this sector. With innovations like AI, deep learning, and photon-counting technology, CT is getting smarter, faster, and more accurate. 🤖 As health care providers seek to address challenges, CT is becoming an essential tool in patient care.🧑⚕️ The global CT market is expected to nearly double, growing from $4 billion in 2021 to over $8 billion by 2030.📊 Learn more about how Computed Tomography is transforming healthcare here: https://lnkd.in/dwJwBSq4 Key Players: FUJIFILM Corporation | GE HealthCare | Hitachi Medical Corp | Neusoft Medical | Philips Health Care | Planmeca | Siemens Healthcare FZ LLC | Toshiba America Medical Systems #healthcare #CTscan #AI #cancer #earlydetection #treatment #patient #article #StratviewResearch

At Cleerly, we're excited about the latest advances in cardiac care that are set to redefine how we detect heart disease in those without symptoms. This article by AJMC - The American Journal of Managed Care dives into how improved CT imaging, updated guidelines, and AI are paving the way for earlier and more accurate diagnoses. Key highlights include: 📝 Expanded Guidelines: New definitions of coronary artery disease (CAD) now include both obstructive and non-obstructive plaque, which is more likely to affect women. 🔍 CCTA Insights: Coronary computed tomography angiography (CCTA) helps quantify plaque and detect disease earlier. 🤖 AI Integration: Emerging AI tools offer enhanced analysis of CCTA scans, potentially transforming patient outcomes. Our own AI technology analyzes CT scans to uncover hidden plaque, stenosis, and likelihood of ischemia, offering a clearer picture of your heart health. As Dr. Maros Ferencik puts it, "We will be able to not only stop the progression of atherosclerosis but actually regress the risk process." 👉 Check out the full article and see how these innovations are set to reshape cardiac care! https://lnkd.in/dwerG9ZV #CardiacCare #YesCCT #HeartDisease #AI #CTImaging

🌟 Exciting times ahead for the healthcare industry as major players increasingly embrace digital health solutions. Philips' announcement of their next-gen cardiovascular ultrasound platform is a significant step forward in improving cardiac analysis and enhancing #PatientCare. This move by Philips underscores the critical importance of integrating AI and advanced technologies into today's #Healthcare landscape. By leveraging cutting-edge innovations, we can significantly improve diagnostic accuracy, patient outcomes, and overall operational efficiency. As we witness more big players entering the #DigitalHealth arena, the opportunities for advancing healthcare become even greater. These technological advancements are not just about innovation; they are about delivering better, faster, and more precise care to patients worldwide. Integrating AI and digital solutions is essential for the future of healthcare. It’s exciting to see industry leaders paving the way and setting new standards for excellence in patient care. 🌐 Read more about Philips’ latest innovation here: https://lnkd.in/eYh6hiMx #DigitalHealth #HealthcareInnovation #AI #CardiacCare #FutureofHealthcare Bjoern von Siemens Dennis Kogan Matt Krueger Amel Mokrani Bois Etienne Bauer Gargee Kashyap Emre kamil Özkan

🎉 Exciting news from our team! - Evidence-based AI We’re thrilled to announce the recent publication of our proof-of-concept study in the Cureus Journal of Medical Science. Read it here: https://lnkd.in/d2JhAD3t We conducted the study in collaboration with the Northumbria Healthcare NHS Foundation Trust, supported by Northumbria University, St. George's University International School of Medicine, and University of Sunderland. Our study showcased the performance of the AIATELLA tool in the assessment of Cardiac MR imaging of the aortic root and valve. The tool was compared against three consultant cardiologists, demonstrating that it is as accurate as the cardiologists and can therefore be relied upon. What’s more, our AI tool produced results over 100x faster than the human experts in the study! This is a promising step forward for our AI, showing its potential to increase the efficiency of care delivery in Cardiovascular medicine. Our next steps are to validate our tool in a large, global cohort to demonstrate its generalisability. We’re fortunate to have research partners in the North East from the NHS, and internationally in Europe, the US, and India, who will be instrumental in this next phase. Stay tuned for more updates as we continue to push the boundaries of AI in healthcare! #aiinhealthcare #radiology #evidencebased #publication

🌟 EchoGo® Amyloidosis is the first AI screening tool to help identify Cardiac Amyloidosis directly from routine echocardiograms. Powered by advanced AI, EchoGo® Amyloidosis seamlessly integrates into clinical workflows, delivering rapid insights that support timely identification and intervention with potentially life saving therapies. ✨EchoGo® Amyloidosis has surpassed current clinical benchmarks, setting a new standard in the detection of cardiac amyloidosis. ✨ Developed in collaboration with Mayo Clinic, Pfizer, and Johnson & Johnson Innovative Medicine 💡 Discover how Ultromics is revolutionizing heart failure detection: https://lnkd.in/e5QzeE-Q #Ultromics #Amyloidosis #EchoGo #MedTech #Cardiology #HeartHealth #HeartFailure #HFpEF #AIinHealthcare #PatientsFirst